Related Experiment Video
Updated: May 22, 2026
11:47
Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
Published on: February 21, 2016
Proteinuria after kidney transplantation
Claudio Ponticelli1, Giorgio Graziani
1Division of Nephrology, Humanitas Scientific Institute, Rozzano, Milano, Italy. ponticelli.claudio@gmail.com
Summary
Proteinuria after kidney transplant, common in mTOR inhibitor users, predicts worse graft survival. Identifying the cause, whether tubular or glomerular, is key for managing transplant outcomes.
Area of Science:
- Nephrology
- Transplantation Immunology
- Renal Medicine
Background:
- Proteinuria is a significant complication following renal transplantation, affecting 11-45% of patients at one year.
- Prevalence is higher in patients treated with mammalian target of rapamycin (mTOR) inhibitors.
- Proteinuria is linked to poorer patient and graft survival rates post-transplant.
Purpose of the Study:
- To elucidate the mechanisms and implications of proteinuria in renal transplant recipients.
- To highlight the prognostic value of proteinuria for allograft outcomes.
- To review current treatment strategies for proteinuria in this population.
Main Methods:
- Review of existing literature on proteinuria post-renal transplantation.
- Categorization of proteinuria into tubular and glomerular mechanisms.
- Analysis of the relationship between proteinuria levels and patient/graft survival.
Main Results:
- Proteinuria arises from either impaired proximal tubular reabsorption or glomerular barrier dysfunction.
- Specific causes include ischemia-reperfusion, rejection, toxic agents, glomerulonephritis, and calcineurin inhibitor toxicity.
- The degree of proteinuria reliably predicts allograft outcome, with even microalbuminuria indicating a poor prognosis.
Conclusions:
- Management of proteinuria hinges on addressing the underlying etiology.
- Renin-angiotensin system (RAS) inhibitors can mitigate microalbuminuria and reduce proteinuria.
- The impact of RAS inhibitors on overall patient and graft survival remains unproven.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...